StockData

RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$4.83−0.47 (-8.87%)

Close on Nov 17, 2026Market cap $200.90MP/E –Yield –

RxSight operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

RxSight's operating cash flow for the twelve months ending Jun 30, 2026 was -$22.73M. For fiscal 2025 it was -$15.51M. The highest annual figure on record is -$15.51M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.51M–
FY2024Dec 31, 2024-$16.95M–
FY2023Dec 31, 2023-$41.59M–
FY2022Dec 31, 2022-$58.85M–
FY2021Dec 31, 2021-$44.71M–
FY2020Dec 31, 2020-$35.20M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.54M–
Q1 FY2026Mar 31, 2026-$10.89M–
Q4 FY2025Dec 31, 2025-$1.12M–
Q3 FY2025Sep 30, 2025-$1.19M-282.6%
Q2 FY2025Jun 30, 2025-$4.38M–
Q1 FY2025Mar 31, 2025-$8.83M–
Q4 FY2024Dec 31, 2024-$4.26M–
Q3 FY2024Sep 30, 2024$650.00K–
Q2 FY2024Jun 30, 2024-$4.03M–
Q1 FY2024Mar 31, 2024-$9.31M–
Q4 FY2023Dec 31, 2023-$8.30M–
Q3 FY2023Sep 30, 2023-$7.98M–
Q2 FY2023Jun 30, 2023-$7.55M–
Q1 FY2023Mar 31, 2023-$17.76M–
Q4 FY2022Dec 31, 2022-$13.85M–
Q3 FY2022Sep 30, 2022-$15.19M–
Q2 FY2022Jun 30, 2022-$14.82M–
Q1 FY2022Mar 31, 2022-$14.99M–
Q4 FY2021Dec 31, 2021-$8.72M–
Q3 FY2021Sep 30, 2021-$13.76M–
Q2 FY2021Jun 30, 2021-$11.98M–
Q1 FY2021Mar 31, 2021-$10.25M–
Q4 FY2020Dec 31, 2020-$8.23M–
Q3 FY2020Sep 30, 2020-$6.95M–

More RxSight figures

See a number that looks wrong?